PMS30 Pharmacoeconomic Evaluation of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Reducing Disease Activity in Patients With Rheumatoid Arthritis
Abstract
Authors
F. Navarro sarabia F.J. Blanco J. Álvaro-Gracia J. García Meijide J. Poveda E. Ruiz-beato